Stay updated on Belzutifan + Cabozantinib in ccRCC Clinical Trial
Sign up to get notified when there's something new on the Belzutifan + Cabozantinib in ccRCC Clinical Trial page.

Latest updates to the Belzutifan + Cabozantinib in ccRCC Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing the previous v3.4.3 revision. This appears to be a metadata/version update with no changes to the page content.SummaryDifference0.0%

- Check14 days agoChange DetectedThe page revision label was updated to v3.4.3, replacing the previous v3.4.2 entry.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedRevision: v3.4.2 was added; the notices about a lapse in government funding and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check50 days agoChange DetectedA top notice informs users of a lapse in government funding and states that the information may not be up to date, with the NIH Clinical Center open and status updates available at opm.gov. The site revision history shows an update to version v3.4.1 (removing v3.4.0); To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedAdded a 'Show glossary' option and updated QC/version metadata (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0), replacing the previous lowercase/counterparts.SummaryDifference0.2%

- Check71 days agoChange DetectedThe changes are limited to revision labels (the page now shows Revision: v3.3.4 and previously displayed v3.3.3), which are minor metadata updates and do not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Belzutifan + Cabozantinib in ccRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belzutifan + Cabozantinib in ccRCC Clinical Trial page.